Posttransplant Lymphoproliferative Disorder after Cardiac Transplantation in Children: Life Threatening Complications Associated with Chemotherapy Combined with Rituximab

about

Posttransplant Lymphoproliferative Disorder after Cardiac Transplantation in Children: Life Threatening Complications Associated with Chemotherapy Combined with Rituximab

Item

http://www.wikidata.org/entity/Q58998353

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2013

@uk

name

Posttransplant Lymphoprolifera ...... herapy Combined with Rituximab

@en

Posttransplant Lymphoprolifera ...... herapy Combined with Rituximab

@nl

type

Item

label

Posttransplant Lymphoprolifera ...... herapy Combined with Rituximab

@en

Posttransplant Lymphoprolifera ...... herapy Combined with Rituximab

@nl

prefLabel

Posttransplant Lymphoprolifera ...... herapy Combined with Rituximab

@en

Posttransplant Lymphoprolifera ...... herapy Combined with Rituximab

@nl

P1476

Posttransplant Lymphoprolifera ...... herapy Combined with Rituximab

@en

P2093

Norihide Fukushima

http://www.w3.org/2001/XMLSchema#string

P2860

The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997

Rituximab therapy in hematologic malignancy patients with circulating blood tumor cells: association with increased infusion-related side effects and rapid blood tumor clearance.

Hemophagocytic syndrome in renal transplant recipients: report of 17 cases and review of literature.

Cardiogenic shock complicates successful treatment of refractory thrombotic thrombocytopenia purpura with rituximab.

Catastrophic gastrointestinal manifestations of post-transplant lymphoproliferative disorder.

Balancing rejection and infection with respect to age, race, and gender: clues acquired from 17 years of cardiac transplantation data.

Minimizing infection and rejection death: clues acquired from 19 years of multi-institutional cardiac transplantation data.

The management of Epstein-Barr virus associated post-transplant lymphoproliferative disorders in pediatric solid-organ transplant recipients.

CD-20 expression in post-transplant lymphoproliferative disorders: treatment with rituximab.

Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease.

P304

1-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5402/2013/683420

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

chemotherapy